This investment will be made by Caplin Point Laboratories Limited and its subsidiaries - Caplin Steriles Limited and Caplin One Labs Limited
The primary goal of this joint venture is to develop and commercialise novel cell therapy products for major unmet medical needs in the United States, Japan, and EU regions
The clearance of this audit marks the successful registration of 8 APIs with CADIFA
Medway setup a state-of-the-art Heart Institute in Chennai
The company has received five final approvals
Liraglutide belongs to the class of glucagon like peptide 1 receptor agonist (GLP?1 RA) drugs
Karkinos Healthcare has demonstrated exceptional dedication to privacy, setting a commendable example for businesses navigating the complexities of the digital landscape
This combination aims to offer an effective tool to manage symptoms of nausea and vomiting during pregnancy
NEIAFMR to be developed as the national hub for folk medicine
The product is expected to be launched in December 2023
Subscribe To Our Newsletter & Stay Updated
